Peer-influenced content. Sources you trust. No registration required. This is HCN.

Essential Medical Reading

Your Weekly Roundup of the Most-Read News and Clinical References from Your Peers

Journal of Clinical Oncology

Overall Survival Remains Important in Trials of Early-Line Multiple Myeloma Therapy

Hematology/Oncology March 29th 2022

Hematology Advisor

Novel Approaches for Monitoring Multiple Myeloma Using cfDNA, Circulating Plasma Cells

Hematology/Oncology March 29th 2022

ASH Clinical News

Long-Term Childhood Hodgkin Lymphoma (HL) Survivors Have Increased Risk of Neurocognitive Impairment

Hematology/Oncology March 29th 2022

JAMA Network

Decade-Long CLL Remission After CAR T-Cell Therapy Reported

Hematology/Oncology March 29th 2022

Journal of Clinical Oncology

A Tribute to Dr. John Cox, the 2021 Joseph V. Simone Awardee: A Champion of Radical Change Transforming Cancer Care Delivery

Oncology, Medical March 29th 2022

Journal of Clinical Oncology

Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study

Oncology, Medical March 29th 2022

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form